pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,498
stories
Aug 17, 26
AstraZeneca touts separate late-stage lung cancer wins with Tagrisso, Enhertu
endpoints
Aug 17, 26
Summit, Akeso's ivonescimab shows smaller benefit with longer follow-up in China
endpoints
Aug 17, 26
STAT+: The IRS is probing UnitedHealth, and a private equity slowdown
stat
Aug 17, 26
Summit, Akeso’s China approval celebration cut short as survival benefit degrades
biospace
Aug 17, 26
STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit
stat
Aug 17, 26
STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more
stat
Aug 17, 26
Celcuity awaits FDA review for second factory to launch cancer drug
endpoints
Aug 17, 26
FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax
biopharma dive
Aug 17, 26
Merck KGaA lays off 20 staffers in latest blow to US research team
fiercebiotech
Aug 17, 26
AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow
biospace
Aug 17, 26
AstraZeneca pulls plug on late-stage lung cancer trial, taking another clinical blow
biospace
Aug 17, 26
AstraZeneca cans late-stage volrustomig trial after lung cancer setback
endpoints
Aug 17, 26
Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate
fiercebiotech
Aug 17, 26
FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify
fiercebiotech
Aug 17, 26
Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vague
fiercebiotech
Aug 17, 26
‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensions
fiercebiotech
Aug 17, 26
How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine
biospace
Aug 17, 26
AstraZeneca ends phase 3 lung cancer trial after bispecific falls short versus Keytruda
fiercebiotech
Aug 17, 26
Recon: FDA approves Zenbexus for multiple myeloma; NSAI seeks buyer for its MDR notified body business
raps
Aug 14, 26
Biogen's monoclonal antibody felzartamab wins first global approval in China
endpoints
Aug 14, 26
STAT+: PBMs agree to display TrumpRx drug prices
stat
Aug 14, 26
STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
stat
Aug 14, 26
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
biopharma dive
Aug 14, 26
Skye and Redx form new entity with $125M to advance fibrosis assets
fiercebiotech
Aug 14, 26
STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
stat
Aug 14, 26
BMS welcomes new multiple myeloma drug as generics batter current portfolio
biospace
Aug 14, 26
Opinion: MAHA and insurance companies both want to treat human bodies like cars
stat
Aug 13, 26
New Taiho, Cullinan data heats up lung cancer drug battle
biopharma dive
Aug 13, 26
Karyopharm has a month left to salvage its cancer expansion plans
endpoints
Aug 13, 26
Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition
biospace
← prev
page 22 of 50
next →
